Thermo Fisher Scientific (TMO) Other Accumulated Expenses (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Other Accumulated Expenses for 18 consecutive years, with $3.7 billion the latest figure, recorded in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $3.7 billion, up 22.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 22.24% YoY), and the FY2025 annual result was $3.3 billion, up 4.06% from the prior year.
• Other Accumulated Expenses was $3.7 billion for Q1 2026 at Thermo Fisher Scientific, up from $3.3 billion in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $3.7 billion in Q1 2026 and troughed at $2.8 billion in Q3 2023.
• Average Other Accumulated Expenses over 5 years is $3.2 billion, with a median of $3.2 billion recorded in 2024.
• Year-over-year, Other Accumulated Expenses soared 58.89% in 2022 and fell 11.17% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $3.4 billion in 2022, then slipped by 3.22% to $3.2 billion in 2023, then dropped by 1.45% to $3.2 billion in 2024, then advanced by 4.06% to $3.3 billion in 2025, then gained by 10.96% to $3.7 billion in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $3.7 billion in Q1 2026, $3.3 billion in Q4 2025, and $3.2 billion in Q3 2025.